Confronted with a persistently elevated activated partial thromboplastin time due to circulating lupus anticoagulant in a patient undergoing emergency off-pump coronary artery bypass surgery, the dilemma of providing adequate anticoagulation for a short cardiac surgical procedure is highlighted.
Get full access to this article
View all access options for this article.
References
1.
MetzdorffMTHansesKSWrightGLFriedSJ. Interference with anticoagulation monitoring by procainamide-induced lupus anticoagulant. Ann Thorac Surg1996; 61: 994–5.
2.
WenzelCStoiserBLockerGJLaczikaKQuehenbergerPKapiotisS. Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions. Crit Care Med2002; 30: 763–70.
3.
DucartARCollardELOsselaerJCBrokaSMEucherPMJouckenKL. Management of anticoagulation during cardiopulmonary bypass in a patient with a circulating lupus anticoagulant. J Cardiothorac Vasc Anesth1997; 11: 878–9.
4.
MyersGJHirschGM. Double valve replacement in a patient with anticardiolipin antibody syndrome. Perfusion1999; 14: 397–401.
5.
RajaSGDreyfusGD. Off-pump coronary artery bypass surgery: to do or not to do? Current best available evidence. J Cardiothorac Vasc Anesth2004; 18: 486–505.
6.
SakakuraMWadaHWatanabeRMamamuroMOkugawaYNakasakiT. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant. Clin Appl Thromb Hemost2000; 6: 144–50.
